Navigation Links
Discovery of Marker for Colon Stem Cells Could Shed Light on What Drives Tumor Growth
Date:4/7/2009

WILMINGTON, Del., April 7 /PRNewswire/ -- Cancer researchers led by Bruce Boman, M.D., Ph.D. director of Cancer Genetics and Stem Cell Biology at the Helen F. Graham Cancer Center of the Christiana Care Health System, and a faculty member at the University of Delaware, have discovered an enzyme common to both normal and malignant colon stem cells that will assist scientists searching for a cure for colon cancer.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090407/DC95299LOGO )

To date, knowledge of a substance, often referred to as a marker, that enables doctors to identify, locate, and isolate normal and malignant colon stem cells, has been elusive. But the discovery by Dr. Boman and colleagues that aldehyde dehydrogenase 1 (ALDH1) is a marker for identifying and isolating colon stem cells is a potential breakthrough in the search for a key to what drives colon cancer growth.

"This is a very important tool for future research," said Boman, M.D., Ph.D., M.S.P.H., and F.A.C.P., who is also a professor of Medical Oncology at Thomas Jefferson University. "Finding a better way to identify, isolate, and track colon cancer stem cells moves us one step closer to understanding what drives tumor growth and to developing new treatments for advanced colon cancer and ways to prevent colon cancer from developing in the first place."

Dr. Boman adds that his team decided to focus on ALDH1 because it had previously been identified as a marker for leukemias, brain cancers, and breast cancer. The researchers found that ALDH1 is a more specific marker for colon cancer stem cells than are other previously identified candidate markers.

In the study, researchers implanted into mice colon stem cells from seven patients diagnosed with colon cancer, and found that the number of ALDH1 cells inc
'/>"/>

SOURCE Christiana Care Health System
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
2. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
3. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
4. ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
5. ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure, Atrial Fibrillation, and Ventricular Arrhythmia
6. Five Clinical Studies to Receive $2.5 Million Under Foundations 2007 Clinical Discovery Program
7. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
8. FASgen Announces New Discovery for Treatment of Stroke
9. Nobel Prize-Winning Discovery
10. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
11. FASgen Announces a New Discovery in Obesity Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... ANGELES , Dec. 17, 2014  ImmunoCellular ... the US Patent and Trademark Office (USPTO) has ... ICT-107, a dendritic cell-based immunotherapeutic vaccine targeting six ... The claims of US Patent No. 8,871,211, which ... neural cancer by administering a dendritic cell composition ...
(Date:12/17/2014)... Dec. 17, 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering, developing and commercializing innovative therapies addressing ... completion of enrollment in its first Phase 2a ... observations confirmed the 1-month findings that were reported ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , ...
(Date:12/17/2014)... -- PCCA received the Autism Hope Alliance,s (AHA) ... seal for best practices in meeting needs in ... materials and goods that meet strict criteria and ... by autism often have unique physical or psychological ... in food and medicine – for instance casein, ...
Breaking Medicine Technology:ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3
... MYL ) today announced that it has ... La Roche Inc. resolving litigation related to XELODA® Tablets, ... Capecitabine Tablets. This product is an orally administered chemotherapeutic ... colorectal cancers. Pursuant to the agreement, ...
... Texas, Sept. 21, 2011 SmallCapVoice.com, Inc. ... Medical Alarm Concepts Holding, Inc. (OTCQB: MDHI), ... medical alarm system that allows the users ... pendant, is now available. The interview can ...
Cached Medicine Technology:Mylan Announces XELODA® Settlement and License Agreement 2A New Audio Interview with Medical Alarm Concepts Holdings, Inc., CEO, Howard Teicher, is now at SmallCapVoice.com 2
(Date:12/15/2014)... 15, 2014 A recent survey found ... women as impacting skin health and beauty were: “Connections,” ... skin care.” Water and health advocate and radio host ... article describing the survey and the Four C’s.* Kleyne ... every category discussed would benefit from paying attention to ...
(Date:12/15/2014)... CARSON CITY, NV (PRWEB) December 15, 2014 ... new powerhouse company, JM Ocean Avenue. JM Ocean ... technology of the Veretekk online automated marketing system. ... by the June 2014 merger of Ocean Avenue and ... a more than $2 Billion per year company. , ...
(Date:12/15/2014)... December 15, 2014 South Florida’s leading urgent ... holidays can be a daze of hassle, hustle, and bustle ... while decking halls, to burns when making special meals and ... that can happen at any time. To prevent this season ... has made a list of helpful and healthful holiday tips ...
(Date:12/15/2014)... 2014 OutMarket , a provider ... Social Media Cheat Sheets ,” a guide that exposes ... results on the top ten social media networks. ... drive awareness, engagement, and customer service. It can also ... an impact on new networks and weather constantly changing ...
(Date:12/15/2014)... By Steven Reinberg ... -- A large, new study should reassure the millions of ... the risk for breast cancer. "There is no association ... Tamimi, an associate professor of medicine at Harvard Medical School. ... for concern, and there is no protective effect either." ...
Breaking Medicine News(10 mins):Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3Health News: No Link Between Migraine, Breast Cancer Risk, Study Says 2
... , ... Shield of Texas has designated Houston Northwest Medical Center as a Blue Distinction Center for ... ... Northwest Medical Center as a Blue Distinction Center for Knee and Hip Replacement. Blue Distinction ...
... ... ... , ... , , ...
... ... ... , , , , ... ...
... , ... ... , , , ... Avon ...
... The National Institutes of Health has awarded a two-year ... the Bradley Hasbro Children,s Research Center to better understand ... disease (IBD), a condition that causes chronic and painful ... grant, funded by the American Recovery and Reinvestment Act ...
... and health care providers need to step up their ... pressure and better treat those with the condition, which ... half of heart failures in the United States each ... Medicine. Policies that create environments which ...
Cached Medicine News:Health News:Houston Northwest Medical Center Has Been Designated as a Blue Distinction Center for Knee and Hip Replacement 2Health News:Houston Northwest Medical Center Has Been Designated as a Blue Distinction Center for Knee and Hip Replacement 3Health News:Houston Northwest Medical Center Has Been Designated as a Blue Distinction Center for Knee and Hip Replacement 4Health News:Federal Government Premium Review Ignores Real Factors Driving Healthcare Costs 2Health News:Federal Government Premium Review Ignores Real Factors Driving Healthcare Costs 3Health News:Federal Government Premium Review Ignores Real Factors Driving Healthcare Costs 4Health News:AARP Makes Senate Vote on Idaho Health Freedom Act 'Accountability Vote' 2Health News:AARP Makes Senate Vote on Idaho Health Freedom Act 'Accountability Vote' 3Health News:AARP Makes Senate Vote on Idaho Health Freedom Act 'Accountability Vote' 4Health News:AARP Makes Senate Vote on Idaho Health Freedom Act 'Accountability Vote' 5Health News:Survey Finds Access to Mammograms Declining for Women Under Age 50 2Health News:Survey Finds Access to Mammograms Declining for Women Under Age 50 3Health News:Survey Finds Access to Mammograms Declining for Women Under Age 50 4Health News:Survey Finds Access to Mammograms Declining for Women Under Age 50 5Health News:Survey Finds Access to Mammograms Declining for Women Under Age 50 6Health News:NIH grant will create behavioral health registry for pediatric inflammatory bowel disease 2Health News:NIH grant will create behavioral health registry for pediatric inflammatory bowel disease 3Health News:IOM report declares high blood pressure a neglected disease 2Health News:IOM report declares high blood pressure a neglected disease 3
... Intuition EMR Ophthalmology is a comprehensive ... tailored for ophthalmology practices. Intuition EMR ... but provides the tools to evaluate ... you to make better decisions and ...
... MaximEyes by First Insight is the ... records solution for eye care professionals. ... with Eyefinitys online servicesrequest VSP authorizations, ... MaximEyes offers EMR, scheduling, billing, demographics, ...
... latest in advanced cartridge mixing and delivery ... and mechanically injects all types of bone ... Revolution&trade line-up includes a large selection of ... in difficult to access areas. A new, ...
Simply stated, no bone cement can match the history of Simplex™. Simplex™ is the only cement with 40 years of proven clinical performance - trusted by tens of thousands of surgeons with o...
Medicine Products: